V. Parikh et M. Singh, RESIDENT CARDIAC MAST-CELLS AND THE CARDIOPROTECTIVE EFFECT OF ISCHEMIC PRECONDITIONING IN ISOLATED RAT-HEART, Journal of cardiovascular pharmacology, 30(2), 1997, pp. 149-156
Our study was designed to investigate the role of resident cardiac mas
t cells in the cardioprotective effect of ischemic preconditioning. Is
chemic/compound 48/80 preconditioning and treatment with compound 48/8
0, a mast cell degranulator (I mu g/ml), produced cardioprotective and
antiarrhythmic effects in isolated perfused rat heart subjected to 30
-min global ischemia followed by 30-min reperfusion. Four episodes of
ischemic/compound 48/80 preconditioning and compound 48/80 treatment m
arkedly reduced the release of lactate dehydrogenase (LDH) and creatin
e kinase (CK) in coronary perfusate and the incidence of ventricular p
remature beats (VPBs) and ventricular tachycardia or fibrillation (VT/
VF) during the reperfusion phase. The release of mast cell peroxidase
(MPO), a marker of mast cell degranulation in coronary perfusate incre
ased immediately after ischemic and compound 48/80 preconditioning. Th
e cardioprotective and antiarrhythmic effect of ischemic/compound 48/8
0 preconditioning was lost within 60 min. It is proposed that the card
ioprotective effect of ischemic preconditioning, which lasts for 60 mi
n in isolated rat heart, may be ascribed to degranulation of resident
cardiac mast cells.